Contract 75F40119D10024
Pharmaron (Exton) Lab Services Llc · Department Of Health And Human Services · September 27, 2023
Pharmaron (Exton) Lab Services Llc was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 27, 2023 for an undisclosed amount of work in research and development in biotechnology (except nanobiotechnology). It was awarded under a small business set-aside. It uses order dependent (idv allows pricing arrangement to be determined separately for each order) contract pricing. If all options are exercised, the contract could reach $3.50 million.
Contract details
- PIID
- 75F40119D10024
- Award type
- —
- Pricing
- Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)
- Set-aside
- Small Business Set Aside - Total
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- R&D- General Science/Technology: Life Sciences (Basic Research)
- First action
- September 27, 2023
Description
UPDATING THE NAME CHANGE OF THE VENDOR FROM ABSORPTION SYSTEMS CALIFORNIA LLC 1547279 TO PHARMARON ( SAN DEIGO) LAB SERVICES .
Modification timeline
-
September 27, 2023Mod P00001 · Novation Agreement$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40119D10024?
Contract 75F40119D10024 is a federal contract awarded to Pharmaron (Exton) Lab Services Llc by Department Of Health And Human Services on September 27, 2023 for an undisclosed amount of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75F40119D10024?
Pharmaron (Exton) Lab Services Llc won contract 75F40119D10024 from Department Of Health And Human Services.
How much is contract 75F40119D10024 worth?
Contract 75F40119D10024 has obligated $0 to date but carries a potential ceiling of $3.50 million if fully funded and all options are exercised.